North America Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
The North America Point of Care (POC) Diagnostics Market is projected to experience substantial growth, with an expected market size of approximately US$ 34,026.8 million by 2031, up from US$ 15,289.0 million in 2024. This growth translates to a compound annual growth rate (CAGR) of 12.2% from 2025 to 2031.
Executive Summary and Market Analysis
The North American POC diagnostics market is divided into three primary regions: the United States, Canada, and Mexico. The market is set for significant expansion during the forecast period, driven by a rise in the prevalence of both infectious and chronic diseases, which necessitate rapid, accurate, and user-friendly diagnostic solutions. Government initiatives and funding aimed at enhancing healthcare infrastructure and developing advanced diagnostic tools are further propelling market growth. Additionally, ongoing research and development (R&D) efforts by leading companies are leading to the introduction of innovative and effective POC testing devices. The integration of advanced technologies, such as digital health tools, miniaturized biosensors, and connectivity solutions, is enhancing the accuracy and accessibility of diagnostic tests. North America maintains its leading position in the global POC diagnostics market, supported by a robust healthcare infrastructure and a high rate of technology adoption.
Market Segmentation Insights
The North America POC Diagnostics Market is segmented by various factors:
The increasing global incidence of infectious diseases is driving the demand for point-of-care diagnostics. Rapid outbreaks necessitate quick, on-site testing to control disease transmission, which in turn fuels innovation in compact and user-friendly diagnostic devices. The ability to obtain immediate results allows for faster clinical decision-making and reduces dependence on centralized laboratories. As the burden of infectious diseases grows, the shift towards decentralized healthcare solutions becomes increasingly critical. POC testing is essential for diagnosing, treating, and preventing infectious diseases, enabling the detection of major pathogens such as HIV, tuberculosis, and various viral infections.
According to the World Health Organization (WHO), the burden of diseases like tuberculosis and HIV remains significant, with millions affected globally. The rising prevalence of healthcare-associated infections (HAIs) further intensifies the need for rapid and accurate POC diagnostics, which facilitate early detection and timely treatment, ultimately improving patient outcomes and alleviating pressure on healthcare systems.
Country Insights
In terms of country-specific insights, the United States holds the largest share of the North America POC diagnostics market as of 2024. The growth in the US market is largely attributed to the increasing incidence of chronic diseases, including cancer and diabetes. For instance, the National Institute of Health reported over 2 million new cancer cases and significant diabetes prevalence among the population. The ongoing advancements in medical technology and the presence of numerous companies focused on developing innovative POC diagnostic solutions further contribute to market growth. Collaborations, such as the one between Mylab Discovery Solutions and Hemex Health, highlight the commitment to advancing POC testing technologies for various diseases, including COVID-19.
Competitive Landscape
Key players in the North America POC diagnostics market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are actively pursuing strategies such as product innovation, market expansion, and mergers and acquisitions to enhance their market presence and offer cutting-edge diagnostic solutions.
Executive Summary and Market Analysis
The North American POC diagnostics market is divided into three primary regions: the United States, Canada, and Mexico. The market is set for significant expansion during the forecast period, driven by a rise in the prevalence of both infectious and chronic diseases, which necessitate rapid, accurate, and user-friendly diagnostic solutions. Government initiatives and funding aimed at enhancing healthcare infrastructure and developing advanced diagnostic tools are further propelling market growth. Additionally, ongoing research and development (R&D) efforts by leading companies are leading to the introduction of innovative and effective POC testing devices. The integration of advanced technologies, such as digital health tools, miniaturized biosensors, and connectivity solutions, is enhancing the accuracy and accessibility of diagnostic tests. North America maintains its leading position in the global POC diagnostics market, supported by a robust healthcare infrastructure and a high rate of technology adoption.
Market Segmentation Insights
The North America POC Diagnostics Market is segmented by various factors:
- By Product: The market includes categories such as Glucose Monitoring, Infectious Disease Testing, Cardio Metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and others. In 2024, Glucose Monitoring held the largest market share.
- By Glucose Monitoring: This segment is further divided into Blood Glucose Meters, Lancets, and Strips, with Strips leading the market share in 2024.
- By Infectious Disease Testing: This includes HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Testing, and others, with Respiratory Infection Testing dominating the market in 2024.
- By Cardio Metabolic Testing: This segment includes tests like Cardiac Troponin (cTn) and Myoglobin Tests, with Cardiac Troponin Tests holding the largest share.
- By Purchase Mode: The market is segmented into Over-the-Counter (OTC) and Prescription, with Prescription products leading in 2024.
- By Sample Type: The market is divided into Blood, Urine, and others, with Blood samples being the most prevalent.
- By End User: The market includes Healthcare Facilities, Homecare, and others, with Healthcare Facilities holding the largest share.
- By Healthcare Facilities: This includes Hospitals, Clinics, and Diagnostic Centers, with Diagnostic Centers leading in 2024.
The increasing global incidence of infectious diseases is driving the demand for point-of-care diagnostics. Rapid outbreaks necessitate quick, on-site testing to control disease transmission, which in turn fuels innovation in compact and user-friendly diagnostic devices. The ability to obtain immediate results allows for faster clinical decision-making and reduces dependence on centralized laboratories. As the burden of infectious diseases grows, the shift towards decentralized healthcare solutions becomes increasingly critical. POC testing is essential for diagnosing, treating, and preventing infectious diseases, enabling the detection of major pathogens such as HIV, tuberculosis, and various viral infections.
According to the World Health Organization (WHO), the burden of diseases like tuberculosis and HIV remains significant, with millions affected globally. The rising prevalence of healthcare-associated infections (HAIs) further intensifies the need for rapid and accurate POC diagnostics, which facilitate early detection and timely treatment, ultimately improving patient outcomes and alleviating pressure on healthcare systems.
Country Insights
In terms of country-specific insights, the United States holds the largest share of the North America POC diagnostics market as of 2024. The growth in the US market is largely attributed to the increasing incidence of chronic diseases, including cancer and diabetes. For instance, the National Institute of Health reported over 2 million new cancer cases and significant diabetes prevalence among the population. The ongoing advancements in medical technology and the presence of numerous companies focused on developing innovative POC diagnostic solutions further contribute to market growth. Collaborations, such as the one between Mylab Discovery Solutions and Hemex Health, highlight the commitment to advancing POC testing technologies for various diseases, including COVID-19.
Competitive Landscape
Key players in the North America POC diagnostics market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are actively pursuing strategies such as product innovation, market expansion, and mergers and acquisitions to enhance their market presence and offer cutting-edge diagnostic solutions.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 PEST Analysis
5. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 North America Point of Care Diagnostics Market Forecast and Analysis
7. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 North America
15.1.1 North America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 North America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 United States: North America Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 United States: North America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 United States: North America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 United States: North America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 United States: North America Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 United States: North America Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 United States: North America Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 United States: North America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Canada: North America Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Canada: North America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Canada: North America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Canada: North America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Canada: North America Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Canada: North America Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Canada: North America Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Canada: North America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 Mexico: North America Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 Mexico: North America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 Mexico: North America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 Mexico: North America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 Mexico: North America Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 Mexico: North America Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 Mexico: North America Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 Mexico: North America Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 PEST Analysis
5. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 North America Point of Care Diagnostics Market Forecast and Analysis
7. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 North America
15.1.1 North America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 North America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 United States: North America Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 United States: North America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 United States: North America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 United States: North America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 United States: North America Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 United States: North America Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 United States: North America Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 United States: North America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Canada: North America Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Canada: North America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Canada: North America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Canada: North America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Canada: North America Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Canada: North America Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Canada: North America Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Canada: North America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 Mexico: North America Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 Mexico: North America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 Mexico: North America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 Mexico: North America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 Mexico: North America Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 Mexico: North America Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 Mexico: North America Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 Mexico: North America Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
LIST OF TABLES
Table 1. North America Point of Care Diagnostics Market Segmentation
Table 3. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 1. North America Point of Care Diagnostics Market Segmentation
Table 3. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
LIST OF FIGURES
Figure 1. North America Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. North America Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. North America Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. North America Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. North America Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. North America Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. North America Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. North America Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. North America Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. North America Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. North America Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. North America Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. North America Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. North America Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. North America Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. North America Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. North America Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. North America Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. North America Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. North America Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
